STRØM Blend

STRØM Blend contains CJC-1295 without DAC and Ipamorelin, two synthetic peptide sequences with distinct but complementary receptor targets commonly studied together in non-human somatotropic axis and growth hormone secretagogue research models. CJC-1295 without DAC is a synthetic GHRH analogue studied in relation to pituitary GHRH receptor binding, somatotropic axis signaling, and growth hormone secretagogue pathway activity in non-human models. Ipamorelin is a synthetic pentapeptide ghrelin receptor agonist studied in relation to GHS-R1a receptor selectivity, pulsatile growth hormone secretagogue signaling, and hypothalamic-pituitary axis pathway behavior. Scientific literature examines these compounds both independently and in combination within neuroendocrine and somatotropic axis research frameworks.

Research applications commonly explored in the literature include:

GHRH receptor binding and somatotropic axis signaling pathway investigation in non-human models

GHS-R1a receptor selectivity and ghrelin receptor agonist activity research

Pulsatile growth hormone secretagogue pathway modeling in hypothalamic-pituitary axis research frameworks

Comparative GHRH analogue and ghrelin receptor agonist co-administration signaling studies

Multi-peptide neuroendocrine axis pathway investigation in controlled non-human laboratory settings

Receptor selectivity and downstream signaling cascade differentiation between GHRH and ghrelin receptor pathways

The lyophilized vial format preserves compound integrity across both peptide sequences within a single preparation, allowing researchers to evaluate reconstitution characteristics, blend stability, and handling parameters under controlled laboratory conditions. Each STRØM Blend vial from KÖLD is prepared and filled in the United States under sterile laboratory conditions. All batches are verified by independent third-party laboratories for purity, volume accuracy, and molecular identity of both peptide components.

1. What are CJC-1295 without DAC and Ipamorelin individually studied for?
   CJC-1295 without DAC is a synthetic GHRH analogue studied in non-human models in relation to pituitary GHRH receptor binding and somatotropic axis signaling pathway activity. Ipamorelin is a synthetic ghrelin receptor agonist studied in relation to GHS-R1a receptor selectivity and pulsatile growth hormone secretagogue signaling. Together, scientific literature examines these compounds within overlapping hypothalamic-pituitary axis and neuroendocrine signaling research frameworks.
2. Why are CJC-1295 without DAC and Ipamorelin studied in combination?
   Scientific literature examines these compounds together due to their complementary receptor targets — CJC-1295 without DAC acts at GHRH receptors while Ipamorelin acts at ghrelin receptors (GHS-R1a). Multi-peptide study designs allow researchers to investigate whether concurrent activation of these two distinct receptor pathways produces differentiated somatotropic axis signaling outcomes compared to single-compound models.
3. What is the significance of CJC-1295 “without DAC” in research contexts?
   DAC (Drug Affinity Complex) is a modification that significantly extends peptide half-life through albumin binding. The without DAC formulation is studied in research models examining shorter-acting GHRH receptor signaling behavior and pulsatile secretagogue activity, allowing researchers to investigate timing-dependent pathway dynamics distinct from the extended-release DAC variant.
4. Is the STRØM Blend approved for any use in humans or animals?
   No. This product is not approved for human or veterinary use. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.
5. How is purity and quality verified for a multi-compound blend? Each STRØM Blend vial undergoes independent third-party laboratory testing to confirm molecular identity, purity, and volume accuracy for both peptide components prior to release. Certificates of Analysis reflect testing results for each compound within the blend.

Before Reconstitution

Store sealed vial in a freezer at -20°C (–4°F)

Keep away from light and humidity

After Reconstitution

Store at 4°C (39°F)

Use within 14 days

Avoid repeated freeze-thaw cycles

This compound is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.